SCHEMBL23748073

SCHEMBL23748073

CCS(=O)(=O)c1c(-c2nc3cc(C(F)(F)C(F)(F)F)nnc3n2C)nc(Br)n1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20393625 0.91 NR1H2 (0.30) —
SCHEMBL24091768 0.89 CNR2 (0.30) —
SCHEMBL30080522 0.85 — —
SCHEMBL23748048 0.84 LMNA (0.34) —
Hydrochloric Acid SCHEMBL30080645 0.83 — —
SCHEMBL21931657 0.82 CNR2 (0.32) —
SCHEMBL29774751 0.82 CNR2 (0.32) —
SCHEMBL30472296 0.82 KDM4E (0.30) —
SCHEMBL25886931 0.82 KDM4E (0.30) —
SCHEMBL23748067 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11479565-B2 Process for preparing substituted imidazole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2022-10-25 — — US disclosed
EP-3864016-B1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES BAYER AG (DE) 2022-09-14 — — EP disclosed
EP-3864016-A1 PROCESS FOR PREPARING SUBSTITUTED IMIDAZOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2021-08-18 — — EP disclosed
CN-112805286-A Process for preparing substituted imidazole derivatives 拜耳公司 2021-05-14 — — CN disclosed
Send feedback